# Statins Evaluation in Coronary Procedures and Revascularization Trial

Study · id `cardio:ct-nct01448642` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01448642](<https://clinicaltrials.gov/study/NCT01448642>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01448642

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 4191 participants.

## Technical summary

Registry record NCT01448642. Randomized; quadruple masking; primary purpose treatment. Start 2012-04 (actual); primary completion 2017-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 4191 participants (enrolled count; ClinicalTrials.gov record NCT01448642, source copy `cardio:ctgov-nct01448642-2019-06-17`, retrieved 2026-10-31)
- Started: 2012-04 (actual) (ClinicalTrials.gov record NCT01448642, source copy `cardio:ctgov-nct01448642-2019-06-17`, retrieved 2026-10-31)
- Primary completion: 2017-11 (actual) (ClinicalTrials.gov record NCT01448642, source copy `cardio:ctgov-nct01448642-2019-06-17`, retrieved 2026-10-31)
- Completion: 2018-04 (actual) (ClinicalTrials.gov record NCT01448642, source copy `cardio:ctgov-nct01448642-2019-06-17`, retrieved 2026-10-31)
- Countries: Brazil (ClinicalTrials.gov record NCT01448642, source copy `cardio:ctgov-nct01448642-2019-06-17`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01448642-2019-06-17`, retrieved 2026-10-31)

## The registry's words

- Brief title: Statins Evaluation in Coronary Procedures and Revascularization Trial
- Acronym: SECURE-PCI
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Atorvastatin
- Intervention (Drug): Placebo
- Lead sponsor: Hospital do Coracao
- Lead sponsor class: OTHER
- Collaborator: Ministry of Health, Brazil
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Hospital do Coracao (`cardio:org-hospital-do-coracao`)
- Registry lists this organization as a collaborator: Ministry of Health, Brazil (`cardio:org-ministry-of-health-brazil`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial (`cardio:pubmed-29525821`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial (`cardio:pubmed-30264159`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5a6e614645243e4726b8f66c26d15b3ba898d7ba20c183ab9d6c4ace5e7470a9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
